Securities Investigation: MEI Pharma Inc.
Are you concerned about your investment in MEI Pharma Inc. at the recommendation of your financial advisor? If so, the securities attorneys at The White Law Group may be able to help you.
MEI Pharma reportedly filed a form D to raise capital from investors in 2018. The total offering amount sold to investors was purportedly $74,999,990.
Private Placements under Regulation D are typically sold by brokerage firms in exchange for a large up-front commission. High commissions can range from 7-10%, as well as additional “due diligence fees” that can range from 1-3%. In this offering, the filing indicates that the sales commissions and fees were estimated at 6% of the total offering amount.
The problem with private placement investments such as MEI Pharma Inc. is that they typically involve a high degree of risk. They are often sold as unregistered securities which lack the same regulatory oversight as more traditional investment products like stocks or bonds. They also tend to be illiquid and when ready to sell, it is often difficult to find a buyer. Although you may be able to sell these investments through a secondary market, it may be at a financial loss.
Potential Lawsuits to Recover Investment Losses
The White Law Group is investigating potential claims involving brokerage firms who may have for improperly recommended high-risk private placements to investors.
Broker dealers are required to perform adequate due diligence on any investment they recommend. They must ensure that all recommendations are suitable for the investor. Firms that fail to do so, may be held responsible for any losses in a FINRA arbitration claim.
FINRA Dispute Resolution is an arbitration venue for investors with claims against their brokerage firm or financial professional. It provides investors with an opportunity to attempt to recoup their investment losses and is an alternative to filing such claims in court.
To learn more, please see: Regulation D Private Placement Fraud Attorneys
If you have concerns regarding your investment in MEI Pharma Inc. and would like to speak with a securities attorney about your options, please call The White Law Group at 888-637-5510 for a free consultation.
The White Law Group, LLC is a national securities fraud, securities arbitration, investor protection, and securities regulation/compliance law firm with offices in Chicago, Illinois and Seattle, Washington.
For more information on The White Law Group and its representation of investors in FINRA arbitration claims, visit https://www.whitesecuritieslaw.com.
Tags: MEI Pharma Inc., MEI Pharma Inc. complaints, MEI Pharma Inc. high commissions, MEI Pharma Inc. investigation, MEI Pharma Inc. investment losses, MEI Pharma Inc. investor relations, MEI Pharma Inc. investors, MEI PHarma lawsuit Last modified: February 21, 2023